Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Ra Capital Management, L.P. reported a 9.90% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event Mar 26, 2026 · Filed Apr 2, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Karyopharm Therapeutics Inc., 2,078,913 shares, as a passive investor on Mar 26, 2026. Filed Apr 2, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 2,078,913
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 2,078,913 |
| Peter Kolchinsky | 9.90% | 2,078,913 |
| Rajeev Shah | 9.90% | 2,078,913 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 2,078,913 |
Source
Related
- Karyopharm Therapeutics Inc.
- Ra Capital Management, L.P.
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026